Validation of Smart Masks for Surveillance of COVID-19

Background: The purpose of this study was to develop and validate a novel “smart mask” capable of passive, real-time surveillance for COVID-19 exposure using colorimetric detection of viral biomarkers. The goal was to create an affordable, easy-to-use diagnostic tool that could integrate seamlessly into daily life, particularly for vulnerable or high-risk populations. This innovation addressed the gap in existing surveillance systems, which required active participation, specialized equipment, or clinical testing.

Materials/Methods: This study involved the design, optimization, and validation of a color-changing smart mask that detected exposure to SARS-CoV-2 proteases. In the first phase, researchers optimized peptide-based reagents to ensure color change occurred only in the presence of two key SARS proteases. These reagents were then incorporated into adhesive test strips that could be attached to standard cloth or surgical masks. The second phase validated the technology using biobanked saliva samples confirmed as COVID-19-positive or -negative to assess analytical sensitivity and specificity. Next, the study evaluated the duration of breathing required by infected individuals for the mask to register a visible color change. In the final phase, field validation was conducted through a surveillance study involving 800 participants at the University of California, San Diego, who concurrently underwent regular PCR testing. Comparative analysis between the smart mask results and PCR tests allowed researchers to calculate the sensitivity, specificity, and accuracy of the device in real-world conditions.

Outcome/Impact: This study demonstrated the feasibility of an innovative, passive COVID-19 surveillance tool that required minimal user effort while providing rapid, visual detection of viral exposure. The integration of optimized colorimetric reagents into a wearable format represented a significant advance in population-level monitoring, offering potential for large-scale, low-cost deployment in healthcare settings, workplaces, and schools. The validation of sensitivity and specificity against PCR testing established a foundation for further refinement and commercialization of the smart mask as a scalable public health tool.